Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of venetoclax combined with
azacitidine regimen for newly diagnosed T-ALL patients.
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Collaborators:
Affiliated Hospital of Nantong University First Affiliated Hospital Bengbu Medical College Jining Medical University Northern Jiangsu Province People's Hospital Suzhou Hospital of Traditional Chinese Medicine The Second People's Hospital of Huai'an